EDGAR Filing Documents for 0001104659-23-113281

Form 8-K - Current report:

SEC Accession No. 0001104659-23-113281

Filing Date

2023-11-01

Accepted

2023-11-01 12:28:35

Documents

Period of Report

2023-10-30

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2329368d4_8k.htm iXBRL	8-K	37853
2	EXHIBIT 1.1	tm2329368d4_ex1-1.htm	EX-1.1	296793
3	EXHIBIT 5.1	tm2329368d4_ex5-1.htm	EX-5.1	18205
4	EXHIBIT 10.1	tm2329368d4_ex10-1.htm	EX-10.1	75366
5	EXHIBIT 99.1	tm2329368d4_ex99-1.htm	EX-99.1	10243
6	EXHIBIT 99.2	tm2329368d4_ex99-2.htm	EX-99.2	11055
10	GRAPHIC	tm2329368d4_ex5-1img001.jpg	GRAPHIC	3327
11	GRAPHIC	tm2329368d4_ex99-1img001.jpg	GRAPHIC	2017
	Complete submission text file	0001104659-23-113281.txt		745106

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	anvs-20231030.xsd	EX-101.SCH	3021
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	anvs-20231030_lab.xml	EX-101.LAB	34240
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	anvs-20231030_pre.xml	EX-101.PRE	22363
13	EXTRACTED XBRL INSTANCE DOCUMENT	tm2329368d4_8k_htm.xml	XML	3405

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312

Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913

Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)